ZIVO Bioscience, Inc.

ZIVO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
Assets
Cash & Equivalents $1.5M $274.4K $1.8M $8.9M $137.9K $346.1K $388.9K $317.1K
Accounts Receivable — — — — — — — —
Inventory — — — — — — — —
Total Current Assets $1.6M $425.4K $1.9M $9.0M $167.8K $369.4K $411.5K $332.3K
Property, Plant & Equipment — $0 $0 $0 $0 $0 $0 $0
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $1.6M $555.7K $2.1M $9.0M $220.2K $369.4K $411.5K $332.3K
Liabilities
Accounts Payable $547.1K $993.1K $490.7K $654.3K $1.6M $1.4M $422.4K $541.7K
Total Current Liabilities $2.0M $2.8M $2.0M $2.9M $11.4M $8.7M $22.7M $4.6M
Long-Term Debt — — — — — — — —
Total Liabilities $2.2M $2.8M $2.1M $2.9M $11.5M $8.7M $22.7M $16.6M
Stockholders' Equity
Retained Earnings $-137.0M $-123.6M $-115.8M $-107.1M $-99.1M $-90.0M $-78.4M $-63.8M
Total Stockholders' Equity $-514.9K $-2.2M $-10.6K $6.0M $-11.3M $-8.3M $-22.3M $-16.3M
← Newer Page 1 of 2 Older →